These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31639691)

  • 1. Differential Expression of Apoptotic and Low-Grade Inflammatory Markers in Alzheimer Disease Compared to Diabetes Mellitus Type 1 and 2.
    Alexandraki KI; Apostolopoulos NV; Adamopoulos C; Stamouli E; Dalagiorgou G; Papaioannou TG; Analitis A; Karamanou M; Makrilakis K; Politis A; Piperi C
    J Appl Lab Med; 2019 May; 3(6):1003-1013. PubMed ID: 31639691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.
    Tan ZS; Beiser AS; Vasan RS; Roubenoff R; Dinarello CA; Harris TB; Benjamin EJ; Au R; Kiel DP; Wolf PA; Seshadri S
    Neurology; 2007 May; 68(22):1902-8. PubMed ID: 17536046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.
    Julian A; Dugast E; Ragot S; Krolak-Salmon P; Berrut G; Dantoine T; Hommet C; Hanon O; Page G; Paccalin M
    Aging Clin Exp Res; 2015 Oct; 27(5):589-94. PubMed ID: 25700558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide.
    Rocha NP; Teixeira AL; Coelho FM; Caramelli P; Guimarães HC; Barbosa IG; da Silva TA; Mukhamedyarov MA; Zefirov AL; Rizvanov AA; Kiyasov AP; Vieira LB; Janka Z; Palotás A; Reis HJ
    Mol Cell Neurosci; 2012 Jan; 49(1):77-84. PubMed ID: 21971579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.
    Alexandraki KI; Piperi C; Ziakas PD; Apostolopoulos NV; Makrilakis K; Syriou V; Diamanti-Kandarakis E; Kaltsas G; Kalofoutis A
    J Clin Immunol; 2008 Jul; 28(4):314-21. PubMed ID: 18224429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression levels of Nurr1 are associated with chronic inflammation in patients with type 2 diabetes.
    Xu Y; Huang Q; Zhang W; Wang Y; Zeng Q; He C; Xue J; Chen J; Hu X; Xu Y
    Mol Med Rep; 2015 Oct; 12(4):5487-93. PubMed ID: 26239742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.
    Wu H; Nie Y; Xiong H; Liu S; Li G; Huang A; Guo L; Wang S; Xue Y; Wu B; Peng L; Song M; Li G; Liang S
    Inflammation; 2015 Dec; 38(6):2076-81. PubMed ID: 26021292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance.
    Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M
    Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients.
    Feng M; Kang M; He F; Xiao Z; Liu Z; Yao H; Wu J
    J Transl Med; 2018 Oct; 16(1):277. PubMed ID: 30305171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production.
    Pellicanò M; Bulati M; Buffa S; Barbagallo M; Di Prima A; Misiano G; Picone P; Di Carlo M; Nuzzo D; Candore G; Vasto S; Lio D; Caruso C; Colonna-Romano G
    J Alzheimers Dis; 2010; 21(1):181-92. PubMed ID: 20413861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation.
    Cimini FA; D'Eliseo D; Barchetta I; Bertoccini L; Velotti F; Cavallo MG
    Cytokine; 2019 Mar; 115():104-108. PubMed ID: 30473178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.
    Tao Q; Ang TFA; DeCarli C; Auerbach SH; Devine S; Stein TD; Zhang X; Massaro J; Au R; Qiu WQ
    JAMA Netw Open; 2018 Oct; 1(6):e183597. PubMed ID: 30646251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D concentrations are associated with nuclear factor kappa-B activity but not with inflammatory markers in healthy normoglycemic adults.
    Mousa A; de Courten MPJ; Forbes J; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():216-222. PubMed ID: 28732679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR15a and miR16 in Chilean type 1 diabetes patients: possible association with apoptosis, inflammatory, or autoimmunity markers.
    Garcia-Diaz DF; Camacho-Guillén P; Codner E; Pérez-Bravo F
    J Endocrinol Invest; 2018 Sep; 41(9):1083-1088. PubMed ID: 29383679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes.
    Herder C; Fürstos JF; Nowotny B; Begun A; Strassburger K; Müssig K; Szendroedi J; Icks A; Roden M;
    Brain Behav Immun; 2017 Mar; 61():137-145. PubMed ID: 28041985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.